Education
About Us
Working with TipRanks
Follow Us
NLS Pharmaceutics (NLSP)
NASDAQ:NLSP
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -11.41K | $ -11.41K | $ -10.05K | $ 0.00 | $ 0.00 |
| Operating Income | $ -11.81M | $ -15.48M | $ -11.86M | $ -2.30M | $ -4.20M |
| EBITDA | $ -11.80M | $ -15.47M | $ -11.85M | $ 0.00 | $ -430.40K |
| Net Income | $ -12.17M | $ -16.50M | $ -11.95M | $ -2.86M | $ -5.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 897.68K | $ 8.95M | $ 5.43M | $ 93.71K | $ 220.27K |
| Total Assets | $ 1.85M | $ 9.28M | $ 5.76M | $ 1.21M | $ 696.43K |
| Total Debt | $ 1.63M | $ 0.00 | $ 0.00 | $ 2.08M | $ 842.13K |
| Net Debt | $ 736.07K | $ -8.95M | $ -5.43M | $ 1.99M | $ 621.86K |
| Total Liabilities | $ 10.68M | $ 6.00M | $ 5.22M | $ 10.20M | $ 6.87M |
| Stockholders' Equity | $ -8.83M | $ 3.28M | $ 542.39K | $ -8.98M | $ -6.17M |
| Cash Flow | |||||
| Free Cash Flow | $ -9.68M | $ -13.88M | $ -14.98M | $ -729.39K | $ -190.01K |
| Operating Cash Flow | $ -9.68M | $ -13.88M | $ -14.94M | $ -729.39K | $ -190.01K |
| Investing Cash Flow | $ 0.00 | - | $ -39.56K | $ 225.64K | - |
| Financing Cash Flow | $ 1.63M | $ 17.40M | $ 20.34M | $ 503.52K | $ 407.48K |
NLS Pharmaceutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.